Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 8INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Classical hematology 2

Conditions

Treatment of Venous Thromboembolism in Cancer Patients 3Venous Thromboembolism 2Neoplasms 2Venous Thrombosis 1Pulmonary Embolism 1Embolism 1Carcinoma, Non-Small-Cell Lung 1

Interventions

apixaban 5Rivaroxaban 5Dalteparin 4Enoxaparin 3edoxaban 2abelacimab 2Tinzaparin 2MAA868 2Heparin, Low-Molecular-Weight 2Dabigatran 2isoquercitrin 1calcium heparin 1betrixaban 1bemiparin 1Warfarin 1Heparin 1Gemcitabine 1Fondaparinux 1AVE 5026 1ALT-836 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Venous Thromboembolism × Heparin, Low-Molecular-Weight × Clear all
NCT04618913 2026-05-26

VICTORIE

Pfizer

Active not recruiting
1 enrolled
Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

Daiichi Sankyo

Phase 3 Completed
1,046 enrolled 24 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡